Charlene Liao
Vorstandsvorsitzender bei Immune-Onc Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Charlene Liao
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Charlene Liao
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Pharmaceuticals: Major | Chief Executive Officer | |
ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
XENCOR, INC. | Biotechnology | Director/Board Member | |
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Chairman | |
Applied StemCell, Inc.
Applied StemCell, Inc. BiotechnologyHealth Technology Applied StemCell, Inc. is a biotechnology company. Its products include stem cell research, genome editing products for cell line generation, primary cells from patient samples and isogenic cell lines. The company was founded by Ruhong Jiang, Ruby Yanru Chen-Tsai and Michael Cleary and is headquartered in Milpitas, CA. | Biotechnology | Director/Board Member | |
NVIGEN, Inc.
NVIGEN, Inc. Medical SpecialtiesHealth Technology NVIGEN, Inc. develops multifunctional and biodegradable nanoparticles. Its products include MagVigen, MaxVigen, MyQuVigen, and AuVigen. The company was founded by Aihua Fu and Guo Liang Yu and is headquartered in Campbell, CA. | Medical Specialties | Founder | |
NEXIMMUNE, INC. | Pharmaceuticals: Major | Director/Board Member | |
QuanDx, Inc.
QuanDx, Inc. Medical SpecialtiesHealth Technology QuanDx, Inc. provides molecular diagnostics. It specializes in the development and commercialization of novel diagnostic tools. The firm provides diagnostic and prognostic information for hematological and solid tumor cancers, as well as a number of infectious diseases. The company was founded by Matthew Lei and Guo-Liang Yu in 2012 and is headquartered in San Jose, CA. | Medical Specialties | Founder | |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Indiana University | College/University | Undergraduate Degree | |
Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree | |
University of California, Davis | College/University | Doctorate Degree | |
University of Iowa | College/University | Doctorate Degree | |
University of the Pacific
University of the Pacific Other Consumer ServicesConsumer Services University of the Pacific is a nationally ranked university with a long tradition of dedicated teaching, small class sizes, practical experience and vibrant residential life. The breathtaking main campus in Stockton, California is home to seven schools and colleges, with more than 80 majors and programs of study. Pacific also has the McGeorge School of Law in Sacramento and the Arthur A. Dugoni School of Dentistry in San Francisco. Total university enrollment is nearly 7,000, with 3,757 undergraduates in an average class size of 19 and a student/faculty ratio of 14:1. It is located in Stockton, California. | College/University | Director/Board Member | |
Fudan University | College/University | Undergraduate Degree | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
National Foundation for Cancer Research
National Foundation for Cancer Research Miscellaneous Commercial ServicesCommercial Services The National Foundation for Cancer Research is a non-profit organization that provides funding to scientists for cancer research. The non-profit company is based in Bethesda, MD. The company's mission is to support life-saving discoveries for cancer patients. | Miscellaneous Commercial Services | Director/Board Member | |
Anhui Medical University | College/University | Graduate Degree | |
The BayHelix Group | Chairman | ||
The Chinese Biopharmaceutical Association | Founder | ||
University of California | College/University | Corporate Officer/Principal | |
The Chinese-American Biopharmaceutical Society
The Chinese-American Biopharmaceutical Society Pharmaceuticals: MajorHealth Technology The Chinese-American Biopharmaceutical Society is a non-profit organization for professionals in the biopharmaceutical industry. The non-profit company is based in San Francisco, CA, the birthplace of biotechnology and one of the largest biomedical hubs in the world. The company's membership consists of life science professionals from a broad range of experience levels, with a large percentage of members holding senior or executive positions in the industry. The society offers year-round sponsorship opportunities, including the highly anticipated 2023 annual BioPacific Conference, and leverages an extensive network of life sciences professionals. | Pharmaceuticals: Major | Director/Board Member | |
Ray Wu Memorial Fund | Director/Board Member | ||
Case Western Reserve University School of Medicine | College/University | Doctorate Degree | |
CROWN BIOSCIENCE INTERNATIONAL | Biotechnology | Chairman | |
PLEXBIO CO., LTD. | Medical Specialties | Director/Board Member | |
Apollomics, Inc. (United States)
Apollomics, Inc. (United States) BiotechnologyHealth Technology Apollomics, Inc. operates as a sciences oncology company. It is a biotechnology company focusing on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company was founded by Sanjeev Gurunath Redkar and Guo-Liang Yu on May 21, 2015 and is headquartered in Foster City, CA. | Biotechnology | Chief Executive Officer | |
Lexent Bio, Inc.
Lexent Bio, Inc. Financial ConglomeratesFinance Lexent Bio, Inc. engages in the development of novel liquid biopsy technologies to manage cancer. The company was founded by Kenneth G. Nesmith, Haluk Tezcan, and John Spinosa and is headquartered in San Francisco, CA. | Financial Conglomerates | Director/Board Member | |
VIELA BIO, INC. | Biotechnology | Chief Executive Officer | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
QYUNS THERAPEUTICS CO., LTD. | Biotechnology | Chairman | |
Zhejiang Crownmab Biotech Co. Ltd. | Chairman | ||
Alpine BioTherapeutics Corp.
Alpine BioTherapeutics Corp. BiotechnologyHealth Technology Alpine BioTherapeutics Corp. engages in the development of stem cell-based therapy to treat blindness. The company was founded by Jiagang Zhao and Ying Wu in 2017 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
Maijin Biomedical Technology (Shanghai) Co., Ltd.
Maijin Biomedical Technology (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Maijin Biomedical Technology (Shanghai) Co. Ltd. provides immunology-related therapeutic areas in China. The company is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
Zhejiang Innoforce Pharmaceuticals Co., Ltd.
Zhejiang Innoforce Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Innoforce Pharmaceuticals Co., Ltd. is a Chinese company that specializes in enabling the innovation and supply of RNA, plasmid DNA, cell and gene therapeutics. The private company is based in Hangzhou, China. The company has a world-class manufacturing and development hub that provides CDMO services. | Pharmaceuticals: Major | Director/Board Member | |
Innoforce Pharmaceuticals Co. Ltd.
Innoforce Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Innoforce Pharmaceuticals Co. Ltd. is a bioinnovation-enabling corporation located in the Hangzhou Bay Biotech Valley within the Hangzhou Airport Economic Demonstration Area. The founders and core management team have extensive international experience and expertise in technology innovation, product development, and business operations. The Chinese company's first phase of the campus covers 21 acres, including biologic process development laboratories, scale-up and R & D labs, and manufacturing facilities for protein, cell, and gene therapies. The company was founded in 2018 by Guo-Liang Yu, Yuling Li, and Zhenhua Wu. Dewan Zeng has been the CEO of the company since 2023. | Pharmaceuticals: Major | Founder | |
Alumis, Inc.
Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a precision medicines company called Esker that aims to provide personalized treatments for people with autoimmune diseases. The company is based in San Francisco, CA. Esker uses a precision analytics platform, powered by foresite labs, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology to create medicines that change the lives of people with autoimmune disease. The company was founded by June H Lee. Martin Babler has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
APOLLOMICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
VISEN Pharmaceuticals
VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member |
Statistik
International
Vereinigte Staaten | 40 |
China | 8 |
Taiwan | 3 |
Vereinigtes Königreich | 2 |
Cayman Islands | 2 |
Sektoral
Health Technology | 31 |
Consumer Services | 11 |
Commercial Services | 5 |
Finance | 3 |
Operativ
Director/Board Member | 21 |
Chairman | 11 |
Corporate Officer/Principal | 9 |
Chief Tech/Sci/R&D Officer | 8 |
Founder | 8 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Guo-Liang Yu | 27 |
Barbara Klencke | 12 |
Zheng Bin Yao | 11 |
Austin L. Gurney | 5 |
Gregory Cosma | 1 |
- Börse
- Insiders
- Charlene Liao
- Unternehmensverbindungen